BioSpace News Archive

Career Advice

Four Clues That It Might Be Time to Start Looking for Another Job

Should you be looking for another job? Or are you actually in a good employment situation, and simply being carried away by others’ experiences on LinkedIn or Facebook?

December 4, 2018
·
4 min read
·
Porschia Parker-Griffin
Drug Development

Karolinska Development’s portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 246

Karolinska Development’s portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US.

December 4, 2018
·
2 min read
Drug Development

MorphoSys Presents Updated Data from L-MIND Study of MOR208 in combination with Lenalidomide in r/r DLBCL at ASH 2018

MorphoSys AG today presented data from the ongoing single-arm phase 2 clinical trial known as L-MIND in an oral presentation at the 60th American Society of Hematology (ASH) Annual Meeting 2018 in San Diego, USA.

December 4, 2018
·
9 min read
Policy

Polyphor announces positive results from the FDA Type B Guidance meeting on the planned Phase III study for balixafortide

The proposed study is intended to support the global registration of balixafortide. Polyphor expects to enroll the first patient in the second quarter of 2019.

December 4, 2018
·
4 min read
Drug Development

ASH: Amgen Ready to Take a BiTE out of Cancer With Immuno-Oncology Platform

At the 60th American Society of Hematology (ASH) Annual Meeting & Exposition, Amgen released the first clinical data from two separate Phase I clinical trials of novel BiTE immunotherapies.

December 4, 2018
·
3 min read
·
Mark Terry
Drug Development

ASH: Seattle Genetics, Takeda Show off Data That Secured Latest FDA Approval for Adcetris

Seattle Genetics and Takeda show off the impressive survival data that prompted the FDA to give approval to Adcetris for this indication.

December 4, 2018
·
3 min read
·
Alex Keown
Drug Development

ASH’s Hot Ticket: BCMA-Targeted CAR-T for B-cell Cancers

Janssen Pharmaceutical, a Johnson & Johnson company, along with Legend Biotech, reported results from their LEGEND-2 Phase I/II clinical trial of CAR-T therapy LCAR-B38M. The therapeutic was being investigated in patients with advanced relapsed or refractory (r/r) multiple myeloma.

December 4, 2018
·
3 min read
·
Mark Terry
Drug Development

ASH: Here’s What Research Has Been Presented on Sickle Cell Disease

At the American Society of Hematology meeting, companies are racing to develop a treatment for SCD, which is an inherited disorder caused by a genetic mutation in the beta-chain of hemoglobin. Some of the data presented by companies were promising, while others reported setbacks.

December 4, 2018
·
4 min read
·
Alex Keown
MTPConnect welcomes additional Federal Government funding

The new funding of $5 million per year for two years through to 2021 from the Industry Growth Centres initiative was announced today by Industry, Science and Technology Minister, Hon Karen Andrews MP at the Growth Centre Showcase at Parliament House in Canberra.

December 4, 2018
·
2 min read
Career Advice

The Myth About Holiday Hiring

There is a common misconception that hiring slows down during November and December. If anything, this is when you should ramp up your efforts to find great candidates. There are several reasons for this.

December 4, 2018
·
2 min read
·
Katie Roth, SHRM-SCP, SPHR